CYRX Cryoport Inc

Price (delayed)

$40.84

Market cap

$1.98B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.42

Enterprise value

$2.37B

Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through ...

Highlights
The revenue rose by 36% year-on-year and by 3.6% since the previous quarter
CYRX's gross profit is up by 29% year-on-year and by 3.6% since the previous quarter
The quick ratio rose by 33% year-on-year but it has declined by 6% since the previous quarter
Cryoport's equity has decreased by 12% YoY and by 7% from the previous quarter
The gross margin has declined by 5% year-on-year

Key stats

What are the main financial stats of CYRX
Market
Shares outstanding
48.49M
Market cap
$1.98B
Enterprise value
$2.37B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.55
Price to sales (P/S)
8.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.34
Earnings
Revenue
$229.59M
EBIT
-$282.95M
EBITDA
-$261.64M
Free cash flow
-$22.22M
Per share
EPS
-$6.42
Free cash flow per share
-$0.46
Book value per share
$11.51
Revenue per share
$4.71
TBVPS
$14.45
Balance sheet
Total assets
$1.05B
Total liabilities
$477.91M
Debt
$430.65M
Equity
$568.42M
Working capital
$581.8M
Liquidity
Debt to equity
0.76
Current ratio
14.21
Quick ratio
13.52
Net debt/EBITDA
-1.5
Margins
EBITDA margin
-114%
Gross margin
42.6%
Net margin
-126%
Operating margin
-11.3%
Efficiency
Return on assets
-29.2%
Return on equity
-48.2%
Return on invested capital
-31.7%
Return on capital employed
-28.2%
Return on sales
-123.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CYRX stock price

How has the Cryoport stock price performed over time
Intraday
-6.11%
1 week
-1.9%
1 month
28.91%
1 year
-25.92%
YTD
-30.98%
QTD
31.83%

Financial performance

How have Cryoport's revenue and profit performed over time
Revenue
$229.59M
Gross profit
$97.81M
Operating income
-$26.01M
Net income
-$289.19M
Gross margin
42.6%
Net margin
-126%
The revenue rose by 36% year-on-year and by 3.6% since the previous quarter
CYRX's gross profit is up by 29% year-on-year and by 3.6% since the previous quarter
Cryoport's operating margin has increased by 25% YoY
Cryoport's operating income has decreased by 6% from the previous quarter and by 2.1% YoY

Growth

What is Cryoport's growth rate over time

Valuation

What is Cryoport stock price valuation
P/E
N/A
P/B
3.55
P/S
8.68
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.34
CYRX's price to book (P/B) is 52% less than its 5-year quarterly average of 7.9 but 5% more than its last 4 quarters average of 3.6
Cryoport's equity has decreased by 12% YoY and by 7% from the previous quarter
CYRX's P/S is 53% below its 5-year quarterly average of 19.5 and 9% below its last 4 quarters average of 10.2
The revenue rose by 36% year-on-year and by 3.6% since the previous quarter

Efficiency

How efficient is Cryoport business performance
CYRX's return on equity has dropped by 177% year-on-year and by 4.6% since the previous quarter
The return on assets has dropped by 128% year-on-year but it has increased by 4.3% since the previous quarter
The company's return on invested capital rose by 14% QoQ
Cryoport's ROS has increased by 2.3% from the previous quarter

Dividends

What is CYRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYRX.

Financial health

How did Cryoport financials performed over time
The total assets is 119% more than the total liabilities
Cryoport's total liabilities has surged by 170% YoY
The quick ratio rose by 33% year-on-year but it has declined by 6% since the previous quarter
The debt is 24% less than the equity
Cryoport's equity has decreased by 12% YoY and by 7% from the previous quarter
The debt to equity is up by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.